ABSTRACT
Understanding the alterations in brain function across different episodes of bipolar disorder (BD), including manic (BipM), depressive (BipD), and remission states (rBD), poses a significant challenge. In our cross-sectional study, we collected resting-state functional magnetic resonance imaging data from 117 BD patients (BipM: 38, BipD: 42, rBD: 37) and 35 healthy controls. Our aim was to delineate functional connections associated with episode dynamics, delineate common and specific patterns, validate them as biomarkers, and elucidate their biological underpinnings. Initially, we identified a common altered pattern within the subregions of the ventral-attention network, alongside specific patterns observed in the default mode network for BipM, the prefrontal network for BipD, and the limbic network for rBD. Using large-sample data from the Human Connectome Project, we further identified that these connectivity patterns exhibit relatively high reliability and heritability. Also, these distinct patterns accurately characterized the diverse episodes of BD and effectively predicted the corresponding clinical symptoms linked with each episode type. Importantly, using out of sample data to decode possible neurobiological mechanisms underlying these patterns, we found that regions of particular interest were enriched in multiple receptors, including MOR, NMDA, and H3 for specific alterations, and A4B2, 5HTT, and 5HT1a for common alterations. Moreover, both episode-specific and common patterns demonstrated a high enrichment for cell types such as L5ET, Micro/PVM,oligodendrites and Chandelier. Our study offers novel insights concerning episode dynamics in BD, paving the way for personalized medicine approaches tailored to address the various episodes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Xiaobo Liu is supported by China Scholarship Council.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of Renmin Hospital of Wuhan University (Ethics Approval Number: WDRY22022-K195).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
